Brainsway Ltd

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. Its Deep Transcranial Magnetic Stimulation platform technology is used to treat major depressive disorder, anxious and late-life depression, obsessive-compulsive disorder, smoking addiction, bipolar disorder, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. The company serves doctors, hospitals, and medical centers in the field of psychiatry. Founded in 2003, it is headquartered in Jerusalem, Israel.